Quantifying blood flow instead of relying on angiography alone led to a change in diagnosis for 53% of patients.

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

There was an increase in the hepatic fat fraction, the long-term consequences of which are unknown, says Robert Rosenson.